Trials / Sponsors / Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Choroidal Neovascularization, Wet Macular Degeneration | Phase 2 | 2018-03-26 |
| Completed | Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma Uveal Melanoma, Choroid Neoplasm | Phase 1 | 2016-05-01 |
| Completed | Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Choroidal Neovascularization, Age-related Macular Degeneration | Phase 2 | 2015-02-01 |
| Completed | Safety and Tolerability Study for Age-Related Macular Degeneration Neovascular Age-Related Macular Degeneration | Phase 1 / Phase 2 | 2010-12-01 |